NEPHROS INC·4

Dec 21, 4:53 PM ET

Spandow Oliver J. 4

4 · NEPHROS INC · Filed Dec 21, 2018

Insider Transaction Report

Form 4
Period: 2018-12-19
Transactions
  • Award

    Stock Option (Right to Buy)

    2018-12-19+46,45746,457 total
    Exercise: $0.65Exp: 2028-12-19Common Stock (46,457 underlying)
Holdings
  • Common Stock

    88,080
  • Stock Option (Right to Buy)

    Exercise: $0.62Exp: 2028-08-10Common Stock (85,199 underlying)
    85,199
Footnotes (3)
  • [F1]Includes 18,030 shares of restricted stock that vest on 6/14/19.
  • [F2]The option vests as to 28,400 shares on each of 8/10/19 and 8/10/20 and as to 28,399 shares on 8/10/21.
  • [F3]On December 19, 2018, the Company granted an option to purchase 46,457 shares of common stock of the Company (the "Option") in respect of the service by Mr. Spandow as a member of the Board of Directors of the Company. The Option was granted under the 2015 Plan. The Option vests as to 15,486 shares on each of 12/19/18 and 12/19/19, and as to 15,485 shares on 12/19/20.

Documents

1 file
  • 4
    edgar.xmlPrimary

    PRIMARY DOCUMENT